TPPHQ - Tapestry Pharma - get a copy of the POR if you can (Colorado District). 20 mm shares O/S. 5 million in claims. Primary asset is a milestone/royalty stream on TPI-287 being advanced through multiple trials by Archer Biosciences. Milestones are worth up to 20 million IF there was full commercialization. Obviously, 90%+ of all drug candidates do not advance to commericialization. There is quite a bit of trial detail on TPI-287 available via google. Royalties would be on top, and Archer does not have worldwide rights - Tapestry has retained significant parts of the globe - another potential asset. The proposed plan, which according to court docs has the support of creditors (there is no CC), would put the assets in a trust and wait for possible success - as opposed to selling the milestone/royalty stream now for whatever they could get for it. Do the math, it's a cheap lotto ticket.
